In utero exposure to medications and congenital eye anomalies
This study provides new data on in utero exposure to medications and congenital eye anomalies that can be severely debilitating. This is a descriptive study, with all the inherent limitations of the pharmacovigilance databases which are used for signal detection. This descriptive study does not allow us to conclude that there is a causal link between exposure to a given medication during pregnancy and congenital eye anomalies and is a basis for future studies using different data sources and/or other methods.
Authors
- Christine Damase‐Michel (ORCID: https://orcid.org/0000-0001-5018-0108)
- Marianne Lepetit (ORCID: https://orcid.org/0009-0001-0265-3182)
- Isabelle M. E. Lacroix (ORCID: https://orcid.org/0000-0003-4185-5753)
- Erika-Alejandra Cifuentes
- R Mairesse
- Charlotte Dubucs
Institutions
- Inserm (FR)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Centre Hospitalier Universitaire de Toulouse (FR)
- Centre de Recherches en Cancérologie de Toulouse (FR)
- Life Medical Control (France) (FR)
Publication Details
- Journal
- BMJ Open Ophthalmology
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1136/bmjophth-2024-002049
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00